Home

Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

La Jolla Pharmaceutical Provides Update On Phase 3 International Riquent(R) Study Thu, 28 Sep 2006 07:00 AM EST ... La Jolla Pharmaceutical Company (Nasdaq: LJPC) announced today considerable progress on its Phase 3 trial of Riquent(R) (abetimus sodium) for the treatment of lupus renal disease. [click link for full article] ... MedicalNewsToday - [read full story...] Related Topics International Health Tolterodine Yoga Phenylephrine and Guaifenesin ER Tablets Guaifenesin and Potassium Guaiacolsulfonate Phenylephrine and Guaifenesin Capsules Rue Psychopharmacology Food Recommendations: South Beach Diet - Phase 1 Food Recommendations: South Beach Diet - Phase 2 Pseudoephedrine and Guaifenesin ER Retinoblastoma Propranolol Peritoneal Dialysis Radiation Studies CHF Diltiazem ER International Classification of Diseases Pseudoephedrine and Guaifenesin Drug Information

GoldBambooTM Your Integrative Health and Wellness Resource November 29, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.